These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 11743172

  • 1. Gene therapy. Gene gemisch cures sickle cell in mice.
    Marshall E.
    Science; 2001 Dec 14; 294(5550):2268. PubMed ID: 11743172
    [No Abstract] [Full Text] [Related]

  • 2. Correction of sickle cell disease in transgenic mouse models by gene therapy.
    Pawliuk R, Westerman KA, Fabry ME, Payen E, Tighe R, Bouhassira EE, Acharya SA, Ellis J, London IM, Eaves CJ, Humphries RK, Beuzard Y, Nagel RL, Leboulch P.
    Science; 2001 Dec 14; 294(5550):2368-71. PubMed ID: 11743206
    [Abstract] [Full Text] [Related]

  • 3. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.
    Alami R, Gilman JG, Feng YQ, Marmorato A, Rochlin I, Suzuka SM, Fabry ME, Nagel RL, Bouhassira EE.
    Blood Cells Mol Dis; 1999 Apr 14; 25(2):110-9. PubMed ID: 10389593
    [Abstract] [Full Text] [Related]

  • 4. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.
    Samakoglu S, Lisowski L, Budak-Alpdogan T, Usachenko Y, Acuto S, Di Marzo R, Maggio A, Zhu P, Tisdale JF, Rivière I, Sadelain M.
    Nat Biotechnol; 2006 Jan 14; 24(1):89-94. PubMed ID: 16378095
    [Abstract] [Full Text] [Related]

  • 5. Gene therapy for the hemoglobin disorders.
    Persons DA, Nienhuis AW.
    Curr Hematol Rep; 2003 Jul 14; 2(4):348-55. PubMed ID: 12901333
    [Abstract] [Full Text] [Related]

  • 6. Globin gene transfer as a potential treatment for the beta-thalassaemias and sickle cell disease.
    Sadelain M.
    Vox Sang; 2004 Jul 14; 87 Suppl 2():235-42. PubMed ID: 15209924
    [No Abstract] [Full Text] [Related]

  • 7. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M.
    Curr Opin Hematol; 2006 May 14; 13(3):142-8. PubMed ID: 16567956
    [Abstract] [Full Text] [Related]

  • 8. Gene therapy for hemoglobinopathies: are we there yet?
    Puthenveetil G, Malik P.
    Curr Hematol Rep; 2004 Jul 14; 3(4):298-305. PubMed ID: 15217560
    [Abstract] [Full Text] [Related]

  • 9. Translational stability for sickle gene therapy.
    Walters MC.
    Gene Ther; 2009 Aug 14; 16(8):943. PubMed ID: 19554033
    [No Abstract] [Full Text] [Related]

  • 10. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
    Bank A, Dorazio R, Leboulch P.
    Ann N Y Acad Sci; 2005 Aug 14; 1054():308-16. PubMed ID: 16339679
    [Abstract] [Full Text] [Related]

  • 11. Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells.
    Oh IH, Fabry ME, Humphries RK, Pawliuk R, Leboulch P, Hoffman R, Nagel RL, Eaves C.
    Exp Hematol; 2004 May 14; 32(5):461-9. PubMed ID: 15145214
    [Abstract] [Full Text] [Related]

  • 12. On the road to gene therapy for beta-thalassemia and sickle cell anemia.
    Bank A.
    Pediatr Hematol Oncol; 2008 May 14; 25(1):1-4. PubMed ID: 18231949
    [Abstract] [Full Text] [Related]

  • 13. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M, Lisowski L, Samakoglu S, Rivella S, May C, Riviere I.
    Ann N Y Acad Sci; 2005 May 14; 1054():78-91. PubMed ID: 16339654
    [Abstract] [Full Text] [Related]

  • 14. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.
    Lebensburger J, Persons DA.
    Curr Opin Drug Discov Devel; 2008 Mar 14; 11(2):225-32. PubMed ID: 18283610
    [Abstract] [Full Text] [Related]

  • 15. Towards the genetic treatment of beta-thalassemia: new disease models, new vectors, new cells.
    Moi P, Sadelain M.
    Haematologica; 2008 Mar 14; 93(3):325-30. PubMed ID: 18310536
    [No Abstract] [Full Text] [Related]

  • 16. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
    Sadelain M, Rivella S, Lisowski L, Samakoglu S, Rivière I.
    Best Pract Res Clin Haematol; 2004 Sep 14; 17(3):517-34. PubMed ID: 15498721
    [Abstract] [Full Text] [Related]

  • 17. Towards gene therapy of hemoglobinopathies.
    Beuzard Y.
    Semin Hematol; 1996 Jan 14; 33(1):43-52. PubMed ID: 8714584
    [No Abstract] [Full Text] [Related]

  • 18. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death.
    Ye L, Chang JC, Lu R, Kan YW.
    Blood Cells Mol Dis; 2008 Jan 14; 41(1):67-72. PubMed ID: 18207438
    [Abstract] [Full Text] [Related]

  • 19. Correction of the sickle cell mutation in embryonic stem cells.
    Chang JC, Ye L, Kan YW.
    Proc Natl Acad Sci U S A; 2006 Jan 24; 103(4):1036-40. PubMed ID: 16407095
    [Abstract] [Full Text] [Related]

  • 20. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
    Siapati EK, Bigger BW, Miskin J, Chipchase D, Parsley KL, Mitrophanous K, Themis M, Thrasher AJ, Bonnet D.
    Mol Ther; 2005 Sep 24; 12(3):537-46. PubMed ID: 16099415
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.